Digestive Health & Nutrition Center offers Gastroenterology specialty healthcare in New Jersey. Dr. Angela Merlo treats adults and children with digestive disorders and provides personalized nutritional counseling alongside advanced gastroenterology procedures including colonoscopy and endoscopy in New Jersey.

Our center also offers SIBO testing in New Jersey, hydrogen breath test options in New Jersey, and non-invasive or minimally invasive testing. Patients have access to telemedicine appointments, and no sedation colonoscopy options are available.

As a pediatric gastroenterologist, Dr. Merlo is dedicated to caring for children with gastrointestinal concerns. Named one of America's Best Physicians and a Top Doctor in Gastroenterology in New Jersey, Dr. Merlo is trusted in Princeton for her exceptional skill, personalized care, and commitment to accurate, minimally invasive diagnosis. Discover how we can help support your health.

Get expert care from a trusted gastroenterologist in New Jersey. We provide comprehensive gastroenterologist procedures in New Jersey, including the hydrogen breath test in New Jersey for accurate digestive diagnostics.

Regulora is a PDT that is accessed through a smartphone app. It consists of seven therapy sessions provided over three months, with practice sessions between. Regulora is delivers Gut-Directed Hypnotherapy (GDH) and includes the collection of adherence data and patient reported outcomes using clinically-validated survey instruments. Unlike most digital therapeutics that focus on behavioral health issues, Regulora treats abdominal pain, a somatic symptom that is the chief IBS complaint. For decades, in-person psychological interventions have been effective in treating IBS but were accessible to very few patients.

Regulora provides broad access to this treatment through a mechanism familiar to both patients and doctors: obtaining a prescription. By providing physicians an easy way to prescribe treatment and patients a convenient way to undergo therapy privately at home, Regulora offers a non-drug option that addresses the stigma often associated with bowel problems and psychological interventions.

metaMe Health is a pioneer in developing Prescription Digital Therapeutics (PDTs). In 2022, our work was recognized by being included on the “50 on Fire” list of up-and-coming Chicago companies, being named one of the Top 150 most promising Digital Health Companies of 2022 nationwide by CBInsights, and being selected as a finalist in the LyfeBulb-Bristol Myers Squibb Inflammatory Bowel Disease Challenge. In 2021, our lead product Regulora® became the first FDA-cleared PDT specifically for abdominal pain associated with irritable bowel syndrome (IBS) in adults. More than 30 million Americans are affected by IBS, and the abdominal pain, diarrhea, and/or constipation that comes with it. Regulora provides relief by digitizing a standardized Brain-Gut therapy approach that has been clinically proven to be effective in reducing IBS symptoms.

Non-drug therapy with no side effects